Navigation Links
Amylin Pharmaceuticals to Present at The Barclays Capital 2010 Global Healthcare Conference
Date:3/16/2010

SAN DIEGO, March 16, 2010 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) will be presenting at the Barclays Capital Global Healthcare Conference on Wednesday, March 24, 2010 at 11:15 a.m. ET / 8:15 a.m. PT in Miami. David Maggs, M.D., vice president, research and development strategic relations at Amylin Pharmaceuticals, will provide a corporate overview.

The presentation will be webcast live through the "Investors" section of Amylin's corporate Web site at www.amylin.com, and a recording will be made available on the Web site following the event. To access the live webcast, please log on to Amylin's site approximately fifteen minutes prior to the presentation to register and download any necessary audio software.

About Amylin Pharmaceuticals

Amylin Phar
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Amylin Pharmaceuticals Initiates Phase 2B Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment in Obesity
2. Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society
3. Amylin and Lilly Announce Plans to Develop Pen Device for Exenatide Once Weekly
4. Amylin Pharmaceuticals Highlights New Data Supporting Therapeutic Potential of Obesity Pipeline at Obesity 2009
5. Amylin Pharmaceuticals Reports Third Quarter Financial Results
6. Amylin Pharmaceuticals and Eli Lilly and Company Statement on FDAs BYETTA(R) (Exenatide) Injection Update
7. Amylin Pharmaceuticals to Present at the 18th Annual Credit Suisse Healthcare Conference
8. Amylin Pharmaceuticals to Webcast Year-End Financial Results
9. Amylin Highlights 2010 Corporate Priorities at J.P. Morgan Healthcare Conference
10. Amylin and Takeda Announce Decision to Advance Development of Pramlintide/Metreleptin Combination Treatment for Obesity
11. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... June 19, 2013   NextDocs announced today ... clinical research organization, at DIA 2013 , the ... will present case studies that explore best practices for ... electronic trial master file (eTMF) systems. ... present alongside Krystyna Kowalczyk , executive vice president ...
(Date:6/19/2013)... CLARA, Calif. , June 19, 2013 /PRNewswire/ ... control solutions for life sciences process applications, announced ... glass bioreactors for upstream cell culture and fermentation.  ... a new product family of Finesse bioreactors and ... and cGMP applications.  They are fully compatible with ...
(Date:6/19/2013)... India , June 19, 2013 ... Bureau has recently added DrugPatentWatch to ... ( http://www.bharatbook.com/drugpatentwatch-tour.pdf )      ... provides comprehensive information on pharmaceutical, drug ... information supports the critical business functions ...
Breaking Medicine Technology:NextDocs and Novella to Present on eTMF at DIA 2013 2Finesse Solutions Launches Next Generation SmartGlass 3L Bioreactors for Cell Culture and Fermentation 2Drug Patent Watch 2Drug Patent Watch 3
... 13 Otix Global, Inc. (Otix) (Nasdaq: OTIX ... today announced that it has decided to discontinue its operations ... decision, Sam Westover, Chairman and CEO of Otix stated, "the ... stability of our business and, as a result, we have ...
... Applied Precision is sending its Mobile ... and research centers.   The Applied Precision ... 40-foot coach bus.  The lab is equipped with Applied ... a wet lab.  New this year is a special ...
Cached Medicine Technology:Otix Global, Inc. to Discontinue German Operations 2Otix Global, Inc. to Discontinue German Operations 3Applied Precision's Mobile Imaging Lab Hits the Road for a Cross-Country Journey 2
(Date:6/19/2013)... medicine and trauma surgery have had a significant ... immediately after major injuries, including burns. Patients ... now are at greatest risk from infections ... sepsis or from inflammation-induced multiorgan failure. ... (MGH) investigators that measures the movement of key ...
(Date:6/19/2013)... (June 19, 2013) In what is believed to ... most common form of hereditary dystonia a movement ... in deep brain stimulation report good success rates and ... the Movement Disorders Program at Cedars-Sinai Medical Center,s Department ... the Division of Neurosurgery at Beth Israel Deaconess Medical ...
(Date:6/19/2013)... The results of three important studies have been published ... journal of the Congress of Neurological Surgeons . ... & Wilkins , a part of Wolters Kluwer ... learning" using artificial neural networks (ANNs) may improve the ... cancers. Another study in the June Neurosurgery ...
(Date:6/19/2013)... Ann Arbor, Mich. Children had half as ... had evening office hours on five or more days ... experts at C.S. Mott Children,s Hospital and Johns Hopkins ... month in The Journal of Pediatrics and ... , "These findings are an important step in understanding ...
(Date:6/19/2013)... is available in Spanish . ... neglected diseases, it goes by the name of the 10/90 ... devoted to conditions that accounted for 90 per cent of ... that the Drugs for Neglected Diseases initiative (DNDi) came into ... organization has been granted the BBVA Foundation Frontiers of Knowledge ...
Breaking Medicine News(10 mins):Health News:Restoring appropriate movement to immune cells may save seriously burned patients 2Health News:Restoring appropriate movement to immune cells may save seriously burned patients 3Health News:Long-term study reports deep brain stimulation effective for most common hereditary dystonia 2Health News:Neurosurgery publishes findings of 3 important studies in June issue 2Health News:Neurosurgery publishes findings of 3 important studies in June issue 3Health News:Extended primary care office hours might help keep kids out of the emergency department 2Health News:DNDi receives the BBVA Foundation Frontiers of Knowledge Award in Development Cooperation 2Health News:DNDi receives the BBVA Foundation Frontiers of Knowledge Award in Development Cooperation 3Health News:DNDi receives the BBVA Foundation Frontiers of Knowledge Award in Development Cooperation 4Health News:DNDi receives the BBVA Foundation Frontiers of Knowledge Award in Development Cooperation 5
... SAN FRANCISCO, Oct. 9 Genomic Health, Inc. (Nasdaq: ... demonstrating the critical role of manual microdissection to remove ... Health,s Onco type DX is the only commercially ... review by a board certified surgical pathologist with breast ...
... and LAKE FOREST, Calif., Oct. 9 Kimberly-Clark Corporation ... IFLO ), a leading healthcare company that develops and ... products for post-surgical pain relief and surgical site care, ... acquired in a cash tender offer for approximately $324 ...
... CEO Harrison Calls for Reform that Eliminates Wasteful Government ... 9 Doug Harrison, CEO and Founder of The SCOOTER ... of Health and Human Services (HHS) Inspector General,s report was ... costs of providing medical equipment to Medicare beneficiaries. , In ...
... of Ford Motor Company and the United Auto Workers are ... - they,re also coming together to support the March of ... start in life. , (Photo: http://www.newscom.com/cgi-bin/prnh/20091009/AQ90045 ) ... Dimes honored special volunteers and announced the first-ever March for ...
... ... employment law compliance obligations can now download a free 75-minute audio briefing entitled Employment ... discussion featuring five employment law attorneys with the Employers Counsel Network. , ... Nashville, TN (PRWEB) October 9, ...
... ... Physical Therapist has received a home exercise program, or HEP, that consisted of 2 to 3 ... FIZIO is a new online service that is set on changing this practice by giving health ... ...
Cached Medicine News:Health News:Genomic Health Announces Data Confirming Manual Microdissection of Biopsy Cavities Is Essential for Accurate Recurrence Risk Assessment in Early-Stage Breast Cancer Patients 2Health News:Genomic Health Announces Data Confirming Manual Microdissection of Biopsy Cavities Is Essential for Accurate Recurrence Risk Assessment in Early-Stage Breast Cancer Patients 3Health News:Genomic Health Announces Data Confirming Manual Microdissection of Biopsy Cavities Is Essential for Accurate Recurrence Risk Assessment in Early-Stage Breast Cancer Patients 4Health News:Genomic Health Announces Data Confirming Manual Microdissection of Biopsy Cavities Is Essential for Accurate Recurrence Risk Assessment in Early-Stage Breast Cancer Patients 5Health News:Kimberly-Clark Announces Definitive Agreement to Acquire I-Flow Corporation 2Health News:Kimberly-Clark Announces Definitive Agreement to Acquire I-Flow Corporation 3Health News:Kimberly-Clark Announces Definitive Agreement to Acquire I-Flow Corporation 4Health News:Kimberly-Clark Announces Definitive Agreement to Acquire I-Flow Corporation 5Health News:Kimberly-Clark Announces Definitive Agreement to Acquire I-Flow Corporation 6Health News:SCOOTER Store CEO Outraged: Flawed Data Used by Fox News Channel to Wrongly Chastise Medical Suppliers 2Health News:Ford and Labor Leaders Join Forces with March of Dimes 2Health News:New Audio Briefing Explains Obama Administration's Workplace Law Priorities 2Health News:New Audio Briefing Explains Obama Administration's Workplace Law Priorities 3Health News:New Online Service Uses Video Instruction to Simplify Physical Therapy Exercises 2Health News:New Online Service Uses Video Instruction to Simplify Physical Therapy Exercises 3Health News:New Online Service Uses Video Instruction to Simplify Physical Therapy Exercises 4
... more efficient way to control thermoregulation. ... operated patient warming system, provides hospitals, ... a compact and better way to ... process. Its unique design combines functionality ...
... WarmAir® system from CSZ safely provides effective ... of the unique patented design of our ... lower velocity blower which supplies gently moving, ... that may spread contaminants to your patient ...
Since 1964, in its plants of Sesto Fiorentino, Sbisà produces a wide and qualified range of instruments for ophthalmology and optometry....
Inquire...
Medicine Products: